tiprankstipranks
Wuxi Biologics (Cayman) Inc. (HK:2269)
HKEX:2269

Wuxi Biologics (Cayman) (2269) Stock Forecast & Price Target

18 Followers
See the Price Targets and Ratings of:

2269 Analyst Ratings

Moderate Buy
3Ratings
2 Buy
1 Hold
0 Sell
Based on 3 analysts giving stock ratings to
Wuxi
Biologics (Cayman)
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

2269 Stock 12 Month Forecast

Average Price Target

HK$29.27
▲(159.53% Upside)
Based on 3 Wall Street analysts offering 12 month price targets for Wuxi Biologics (Cayman) in the last 3 months. The average price target is HK$29.27 with a high forecast of HK$42.00 and a low forecast of HK$16.60. The average price target represents a 159.53% change from the last price of HK$11.28.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"10":"HK$10","29":"HK$29","48":"HK$48","19.5":"HK$19.5","38.5":"HK$38.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":42.0000011104506,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n  <span style=\"color:#199ca5\">HK$42.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":29.27476875,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n  <span style=\"color:#828080\">HK$29.27</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":16.60000043889238,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n  <span style=\"color:#912767\">HK$16.60</span>\n  </div></div>","useHTML":true}}],"tickPositions":[10,19.5,29,38.5,48],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2023","6":"Jan<br/>2024","9":"Apr<br/>2024","12":"Jul<br/>2024","25":"Jul<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,11.26,13.624615470034662,15.989230940069323,18.353846410103984,20.718461880138648,23.083077350173305,25.44769282020797,27.812308290242633,30.17692376027729,32.541539230311955,34.90615470034661,37.270770170381276,39.63538564041594,{"y":42.0000011104506,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,11.26,12.645751442307692,14.031502884615385,15.417254326923077,16.80300576923077,18.188757211538462,19.574508653846152,20.960260096153846,22.34601153846154,23.731762980769233,25.117514423076926,26.503265865384616,27.889017307692306,{"y":29.27476875,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,11.26,11.670769264530183,12.081538529060365,12.492307793590548,12.903077058120733,13.313846322650916,13.724615587181098,14.135384851711281,14.546154116241464,14.956923380771649,15.36769264530183,15.778461909832014,16.1892311743622,{"y":16.60000043889238,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":44.6,"date":1690848000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":44.35,"date":1692921600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":44.15,"date":1693526400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":43.7,"date":1696550400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":47.95,"date":1698969600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.35,"date":1701993600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.55,"date":1704412800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.78,"date":1706832000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.8,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.36,"date":1712275200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.96,"date":1714694400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.38,"date":1717718400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.26,"date":1720137600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price TargetHK$42.00Average Price TargetHK$29.27Lowest Price TargetHK$16.60
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Analyst Performance
Any
Any
Analyst Rating
Any
Any
Upside / Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Goldman Sachs
HK$21.6HK$19.4
Hold
HK$19.40
(71.99% Upside)
Reiterated
04/11/24
Wuxi Biologics (2269:HK) (WXXWY) PT Lowered to HK$19.40 at Goldman SachsGoldman Sachs analyst Ziyi Chen lowered the price target on Wuxi Biologics (2269:HK) (OTC: WXXWY) to HK$19.40 (from HK$21.60) while maintaining a Neutral rating.
J.P. Morgan
HK$34HK$15
Hold
HK$15.00
(32.98% Upside)
Reiterated
04/02/24
Wuxi Biologics (2269:HK) (WXXWY) PT Lowered to HK$15 at JPMorganJPMorgan analyst Yang Huang lowered the price target on Wuxi Biologics (2269:HK) (OTC: WXXWY) to HK$15.00 (from HK$34.00) while maintaining a Neutral rating.
Macquarie
HK$38HK$14
Hold
HK$14.00
(24.11% Upside)
Reiterated
03/28/24
Wuxi Biologics (2269:HK) (WXXWY) PT Lowered to HK$14 at MacquarieMacquarie analyst Tony Ren lowered the price target on Wuxi Biologics (2269:HK) (OTC: WXXWY) to HK$14.00 (from HK$38.00) while maintaining a Neutral rating.
CMB International Securities
HK$39.65HK$18.32
Buy
HK$18.32
(62.41% Upside)
Reiterated
03/28/24
Buy Rating Affirmed for WuXi Biologics Amid Strong Non-COVID Revenue Growth and Strategic European Expansion
Nomura
HK$58.44HK$53.65
Buy
HK$53.65
(375.62% Upside)
Reiterated
02/29/24
Wuxi Biologics (2269:HK) (WXXWY) PT Lowered to HK$53.65 at Nomura/InstinetNomura/Instinet analyst Jialin Zhang lowered the price target on Wuxi Biologics (2269:HK) (OTC: WXXWY) to HK$53.65 (from HK$58.44) while maintaining a Buy rating.
Bernstein
HK$52
Buy
HK$52.00
(360.99% Upside)
Reiterated
02/13/24
Wuxi Biologics: Navigating the Biosecure Act with Resilience and Optimism
CLSA
HK$37
Buy
HK$37.00
(228.01% Upside)
Upgraded
01/11/24
CLSA Upgrades Wuxi Biologics (2269:HK) (WXXWY) to Buy (1)CLSA analyst Michael Luo upgraded Wuxi Biologics (2269:HK) (OTC: WXXWY) from Outperform (2) to Buy (1) with a price target of HK$37.00.

Best Analysts Covering Wuxi Biologics (Cayman)

Which Analyst Should I Follow If I Want to Buy HK:2269 and Sell After:
1 Month
xxx
Success Rate
0/4 ratings generated profit
0%
Average Return
-17.32%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 0.00% of your transactions generating a profit, with an average return of -17.32% per trade.
3 Months
xxx
Success Rate
0/4 ratings generated profit
0%
Average Return
-28.35%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -28.35% per trade.
1 Year
Chris LuiJefferies
Success Rate
0/5 ratings generated profit
0%
Average Return
-44.38%
reiterated a buy rating 2 months ago
Copying Chris Lui's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -44.38% per trade.
2 Years
xxx
Success Rate
0/5 ratings generated profit
0%
Average Return
-49.78%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -49.78% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

2269 Analyst Recommendation Trends

Rating
Feb 24
Mar 24
Apr 24
May 24
Jun 24
Strong Buy
8
6
4
4
3
Buy
1
0
1
1
1
Hold
3
2
3
3
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
12
8
8
8
7
In the current month, 2269 has received 4 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. 2269 average Analyst price target in the past 3 months is HK$29.27.
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

2269 Financial Forecast

2269 Earnings Forecast

Next quarter’s earnings estimate for 2269 is HK$0.44 with a range of HK$0.44 to HK$0.44. The previous quarter’s EPS was HK$0.28. 2269 beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 41.32% of the time in the same period. In the last calendar year 2269 has Outperformed its overall industry.
Next quarter’s earnings estimate for 2269 is HK$0.44 with a range of HK$0.44 to HK$0.44. The previous quarter’s EPS was HK$0.28. 2269 beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 41.32% of the time in the same period. In the last calendar year 2269 has Outperformed its overall industry.

2269 Sales Forecast

Next quarter’s sales forecast for 2269 is HK$8.51B with a range of HK$8.51B to HK$8.51B. The previous quarter’s sales results were HK$9.23B. 2269 beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 55.77% of the time in the same period. In the last calendar year 2269 has Outperformed its overall industry.
Next quarter’s sales forecast for 2269 is HK$8.51B with a range of HK$8.51B to HK$8.51B. The previous quarter’s sales results were HK$9.23B. 2269 beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 55.77% of the time in the same period. In the last calendar year 2269 has Outperformed its overall industry.

2269 Stock Forecast FAQ

What is HK:2269’s average 12-month price target, according to analysts?
Based on analyst ratings, Wuxi Biologics (Cayman) Inc.’s 12-month average price target is HK$29.27.
    What is HK:2269’s upside potential, based on the analysts’ average price target?
    Wuxi Biologics (Cayman) Inc. has 159.53% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Wuxi Biologics (Cayman) Inc. a Buy, Sell or Hold?
          Wuxi Biologics (Cayman) Inc. has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 1 hold ratings and 0 sell ratings.
            What is Wuxi Biologics (Cayman) Inc.’s share price target?
            The average share price target for Wuxi Biologics (Cayman) Inc. is HK$29.27. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is HK$42.00 ,and the lowest forecast is HK$16.60. The average share price target represents 159.53% Increase from the current price of HK$11.28.
              What do analysts say about Wuxi Biologics (Cayman) Inc.?
              Wuxi Biologics (Cayman) Inc.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 3 Wall Streets Analysts.
                How can I buy shares of Wuxi Biologics (Cayman) Inc.?
                To buy shares of HK:2269, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis